By contrast, knockdown of heparanase or treatments of tumor-bearing mice with heparanase-inhibiting compounds markedly attenuate tumor progression, underscoring the potential of anti-heparanase therapy for multiple types of cancer and encouraging the development of heparanase inhibitors as anti-cancer drugs [12,14]. The gene discussed is HPSE; the disease is neoplasm.